SpyGlass Pharma Inc SGP Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$36.95 up $2.87, 8.41% at close Nov 6
Last close · Previous close $34.08
- Market cap
- At the Nov 6 close
- Dividend yield
- NoneLast 12 months
Price chart
$36.95up $2.87, 8.41%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$34.08Nov 5
- Volume109.35KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume102.59KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $17.06 to $37.12; now $36.95
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
SGP beat the S&P 500 in both periods.
| Period | SGP and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SGP: up 49.1% S&P 500: down 5.6% | SGP beat the S&P 500 by 54.7 percentage points Beat |
| 3M | SGP: up 49.3% S&P 500: down 4.1% | SGP beat the S&P 500 by 53.4 percentage points Beat |
SGP beat the S&P 500 in both periods.
| Period | SGP and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SGP: up 49.1% S&P 500: down 5.6% | SGP beat the S&P 500 by 54.7 percentage points Beat |
| 3M | SGP: up 49.3% S&P 500: down 4.3% | SGP beat the S&P 500 by 53.6 percentage points Beat |
All-time high
$36.95
Closing high on .
Split-adjusted daily closes since Feb 6, 2026.
Stock splits
SGP hasn’t split since its price history begins in 2026.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- Not reported
- Net income
- Not reported
- Diluted EPS
- Not reported
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY23 (Dec 31, 2023) | Not reported | Not reported | Not reported |
| Q4 FY24 (Dec 31, 2024) | $0.00 | −$8.40M | −$4.59 |
| Q1 FY25 (Mar 31, 2025) | $0.00 | −$8.82M | −$3.96 |
| Q2 FY25 (Jun 30, 2025) | $0.00 | −$8.68M | −$3.81 |
| Q3 FY25 (Sep 30, 2025) | Not reported | Not reported | Not reported |
| Q4 FY25 (Dec 31, 2025) | $0.00 | −$12.56M | −$5.70 |
| Q1 FY26 (Mar 31, 2026) | $0.00 | −$13.82M | −$0.69 |
| Q2 FY26 (Jun 30, 2026) | $0.00 | −$19.86M | −$0.59 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY23 (Dec 31, 2023) | $0.00 | −$13.32M | −$1.34 |
| FY24 (Dec 31, 2024) | $0.00 | −$29.16M | −$16.31 |
| FY25 (Dec 31, 2025) | $0.00 | −$39.87M | −$17.98 |
Margins
- Gross —
- Operating —
- Net —
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- Not reportedLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flowNot reportedLast 12 months
- Capital spendingNot reportedLast 12 months
Shareholder returns
- Not reportedLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paidNot reportedLast 12 months
Balance sheet
- $234.19MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$1.63MAs of Jun 30, 2026
- Net cash$232.55MAs of Jun 30, 2026
- 25.06As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.01As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
About SpyGlass Pharma Inc
SpyGlass Pharma Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
SGP news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
SGP stock FAQ
What is SGP stock’s price today?
SpyGlass Pharma (SGP) traded at $36.95 at the close on , up $2.87 (8.41%) from the previous close of $34.08. Over the past 52 weeks it has traded between $17.06 and $37.12.
Does SGP pay a dividend?
SpyGlass Pharma hasn’t paid a dividend in the last twelve months.
What is SGP’s 52-week high and low?
Over the past 52 weeks SGP has traded as low as $17.06 and as high as $37.12. At $36.95 at the close on , it is 0.5% below that high and 116.6% above the low.
What is SGP’s all-time high?
SGP’s highest closing price was $36.95 on , adjusted for stock splits.
Has SGP stock ever split?
No. SGP hasn’t split since its price history begins in 2026.
What sector and industry is SpyGlass Pharma in?
SpyGlass Pharma is in the Healthcare sector and the Biotechnology industry, and is headquartered in California, USA.
What exchange does SGP trade on?
SpyGlass Pharma trades on the Nasdaq under the ticker symbol SGP. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.